Traitement médical des rechutes (récidives) précoces

Piura B, Rabinovich A, Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma. European Journal of Gynaecological Oncology. ,vol. 25, pp. 449- 452 ,(2004)

P G Rose, J A Blessing, A R Mayer, H D Homesley, Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. Journal of Clinical Oncology. ,vol. 16, pp. 405- 410 ,(1998) , 10.1200/JCO.1998.16.2.405

R F Ozols, Y Ostchega, G Curt, R C Young, High-dose carboplatin in refractory ovarian cancer patients. Journal of Clinical Oncology. ,vol. 5, pp. 197- 201 ,(1987) , 10.1200/JCO.1987.5.2.197

Chris Williams, Iveta Simera, Andrew Bryant, Tamoxifen for relapse of ovarian cancer. Cochrane Database of Systematic Reviews. ,(2010) , 10.1002/14651858.CD001034.PUB2

Michael A. Bookman, Extending the platinum-free interval in recurrent ovarian cancer: the role of topotecan in second-line chemotherapy. Oncologist. ,vol. 4, pp. 87- 94 ,(1999) , 10.1634/THEONCOLOGIST.4-2-87

E L Trimble, J D Adams, D Vena, M J Hawkins, M A Friedman, J S Fisherman, M C Christian, R Canetta, N Onetto, R Hayn, Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. Journal of Clinical Oncology. ,vol. 11, pp. 2405- 2410 ,(1993) , 10.1200/JCO.1993.11.12.2405

Martine J. Piccart, John A. Green, Angel Jimenez Lacave, Nick Reed, Ignace Vergote, Pierluigi Benedetti-Panici, Andrea Bonetti, Vera Kristeller-Tome, Cesar Mendiola Fernandez, Desmond Curran, Martine Van Glabbeke, Denis Lacombe, Marie-Claire Pinel, Serge Pecorelli, Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group Journal of Clinical Oncology. ,vol. 18, pp. 1193- 1202 ,(2000) , 10.1200/JCO.2000.18.6.1193

Alan N. Gordon, John T. Fleagle, David Guthrie, David E. Parkin, Martin E. Gore, Angel J. Lacave, Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan Journal of Clinical Oncology. ,vol. 19, pp. 3312- 3322 ,(2001) , 10.1200/JCO.2001.19.14.3312

Montaser Shaheen, Michael J. Stender, John W. McClean, Katherine Y. Look, Lawrence H. Einhorn, Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study. American Journal of Clinical Oncology. ,vol. 27, pp. 229- 231 ,(2004) , 10.1097/01.COC.0000054896.56416.79

P A Vasey, L McMahon, J Paul, N Reed, S B Kaye, A phase II trial of capecitabine (Xeloda ® ) in recurrent ovarian cancer British Journal of Cancer. ,vol. 89, pp. 1843- 1848 ,(2003) , 10.1038/SJ.BJC.6601381